Gentamicin and Nilstat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gentamicin (gentamicin sulfate) and Nilstat (nystatin). Common drug interactions include acute myeloid leukaemia among females and acidosis among males.

The phase IV clinical study analyzes what interactions people have when they take Gentamicin and Nilstat. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Gentamicin?

Gentamicin has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 21,654 Gentamicin users. Check the latest studies of Gentamicin.

What is Nilstat?

Nilstat has active ingredients of nystatin. eHealthMe is studying from 498 Nilstat users. Check the latest studies of Nilstat.



On Jul, 06, 2026

18 people who take Gentamicin and Nilstat together, and have interactions are studied.

Gentamicin and Nilstat drug interactions.

What are the common drug interactions of Gentamicin and Nilstat, by gender? *:

female:

  1. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  2. Death
  3. Acute lymphocytic leukaemia (cancer of the white blood cells)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Psychotic disorder
  6. Drug hypersensitivity
  7. Petechiae (a small red or purple spot caused by bleeding into the skin)
  8. Vasculitis (inflammation of a blood vessel or blood vessels)

male:

  1. Acidosis (build-up of carbon dioxide in the blood)
  2. Dehydration (dryness resulting from the removal of water)
  3. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  4. Ileal perforation
  5. Lipase increased
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Renal failure (kidney dysfunction)
  8. Rhinovirus infection
  9. Hypokalaemia (low potassium)
  10. Pancreatitis (inflammation of pancreas)

What are the common drug interactions of Gentamicin and Nilstat, by age (0-1 to 60+)? *:

0-1:

  1. Ileal perforation
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Vasculitis (inflammation of a blood vessel or blood vessels)
  2. Petechiae (a small red or purple spot caused by bleeding into the skin)

50-59:

  1. Renal failure (kidney dysfunction)

60+:

  1. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  2. Death
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Skin exfoliation (removal of the oldest dead skin cells)
  6. Wound infection
  7. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  8. Rhinovirus infection

What are the existing conditions these people have? *

  1. Oral Candidiasis (fungal infection of mouth): 6 people, 33.33%
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 33.33%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 22.22%
  4. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 22.22%
  5. Depression: 4 people, 22.22%
  6. Diarrhea: 3 people, 16.67%
  7. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 3 people, 16.67%
  8. Infusion Related Reaction: 3 people, 16.67%
  9. Mucosal Inflammation (infection of mucous membrane): 3 people, 16.67%
  10. Muscle Spasms (muscle contraction): 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Gentamicin and Nilstat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gentamicin and Nilstat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nilstat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gentamicin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nilstat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate and nystatin (the active ingredients of Gentamicin and Nilstat, respectively), and Gentamicin and Nilstat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: